# BONIRA — Production Journey Risk & Coverage Assessment

Continue on BONIRA current `main`.

## Objective

Perform a **read-only Production Journey Risk & Coverage Assessment** over the prepared canonical Journey inventory.

This is an assessment/evidence-mapping task only. Do not execute new journeys or mutate the product.

## Canonical inventory

Use:

`docs/governance/journeys/BONIRA_JOURNEY_RISK_COVERAGE_ASSESSMENT.xlsx`

The workbook contains **608 current Journey rows** reconciled from the prior 584-row inventory at `d75a9334d8e27683159c5f756725c0540651ec43` to current `main` baseline `4817aa2c50258e2ed741f3617d868bf1d65e5f79`.

Treat those 608 rows as the **authoritative canonical Journey Inventory for this assessment**.

**Do NOT rediscover, regenerate, reconstruct, enumerate, or reconcile the Journey list from the codebase.**

The task is **risk classification + evidence mapping + gap identification**, not Journey discovery.

If repository inspection reveals a materially important journey that appears absent, do not insert it into the 608-row inventory. Record it separately as `Candidate Missing Journey` with exact source evidence.

## Repository grounding

Before assessment:

1. confirm branch `main`;
2. record current HEAD;
3. compare HEAD with workbook baseline `4817aa2c50258e2ed741f3617d868bf1d65e5f79`;
4. if HEAD differs, do not rebuild the inventory. Record the delta SHA/range and assess whether it can materially affect Journey coverage. Mark only affected rows for later delta recheck.

No Git writes.

## Evidence source hierarchy

Use evidence in this order. Do not broadly inspect source code when a higher-level canonical artifact already answers the question.

1. Canonical workbook above.
2. `CEP_EXECUTION_REGISTRY.yaml`.
3. `docs/governance/cep/reports/`.
4. `docs/governance/cep/evidence/CEP-079_ENTRY_PREPARATION_01/44_CASE_READINESS_MATRIX.csv` and the current `CEP-079_COMPLETION_REPORT.md`.
5. Existing CEP acceptance/evidence/change/execution manifests.
6. Focused automated tests and repository source code **only when documentary evidence is insufficient or ambiguous**.

Do not rerun Audits 01–20.
Do not recreate CEP evidence already present.

## Important evidence rule

A completed CEP does **not automatically prove every Journey in that domain**.

Map evidence to a Journey only when the artifact/test/runtime case actually supports that Journey's path and relevant authority/lifecycle boundary.

`CEP-079` completed **44/44 representative scenarios and 48/48 mappings**, but it explicitly did **not** provide exhaustive acceptance of all 608 Journeys.

Therefore do not mark a Journey `RUNTIME_PROVED` merely because it belongs to a domain touched by CEP-079.

## Pass 1 — all 608 Journeys

For every existing row, fill the prepared assessment columns only. Preserve the Journey ID, Domain, Level, Journey, Path and current static disposition.

Fill:

- `risk_level`: `Critical / High / Medium / Low`
- `business_criticality`
- `financial_impact`
- `authorization_security_impact`
- `cep079_coverage`
- `prior_cep_evidence`
- `runtime_evidence`
- `automated_evidence`
- `coverage_confidence`: `High / Medium / Low`
- `coverage_status`
- `pre_production_action`
- `post_cep069_078_recheck`: `YES / NO`
- `evidence_refs`
- `evidence_urls` or repository paths
- `assessment_note`

Use these `coverage_status` values only:

- `RUNTIME_PROVED`
- `AUTOMATED_PROVED`
- `DOCUMENTED_IMPLEMENTED`
- `PARTIAL_EVIDENCE`
- `UTV`
- `NOT_APPLICABLE`

## Risk classification

### Critical

Use when failure can materially affect:

- accounting/GL posting or financial statements;
- cash/receipt/payment/settlement;
- Payroll finalization/disbursement/statutory obligations;
- contract/claim/certificate financial approval;
- regulatory/tax/insurance treatment;
- tenant isolation or sensitive authorization;
- protected approval/maker-checker controls;
- immutable financial/history correction/reversal;
- inventory valuation or material financial recognition;
- production closeout/readiness;
- other similarly irreversible or production-blocking outcomes.

### High

Material business, data-integrity, cross-domain, approval or operational consequences, but below the Critical threshold.

### Medium

Normal operational workflows with bounded recovery and limited systemic impact.

### Low

Low-impact/read-only/convenience/variant journeys where representative or automated evidence can reasonably suffice.

Do not downgrade risk merely because automated tests exist. Risk and evidence are separate dimensions.

## Pass 2 — targeted deep review only

After Pass 1, deep-inspect **only** Journeys where:

- `risk_level` is `Critical` or `High`; and
- `coverage_status` is `PARTIAL_EVIDENCE` or `UTV`, **or** `coverage_confidence` is not `High`.

For those rows only:

1. inspect the relevant CEP completion/evidence artifacts;
2. inspect focused tests if needed;
3. inspect source code only if the evidence contract remains ambiguous;
4. refine the evidence mapping and pre-production action.

Do not deep-read every source file for all 608 rows.

## Coverage interpretation

- `RUNTIME_PROVED`: actual runtime/browser/service workflow evidence proves the relevant Journey within a representative environment and boundary.
- `AUTOMATED_PROVED`: focused integration/functional tests prove the Journey contract, but no sufficient runtime/UAT evidence exists.
- `DOCUMENTED_IMPLEMENTED`: implementation is evidenced by accepted CEP artifacts but executable journey-specific proof is insufficient.
- `PARTIAL_EVIDENCE`: some steps/controls are proved but an important part of the Journey is not.
- `UTV`: no sufficient current evidence found.
- `NOT_APPLICABLE`: retired/historical/non-current authoritative path.

Absence of evidence is a **coverage gap**, not automatically a product defect.

## Production-readiness decision support

The purpose is not to demand 608 manual UAT executions.

Identify the minimum additional pre-production verification needed after the planned `CEP-069..078` work.

For each Critical/High gap, state whether the eventual action should be:

- additional browser/runtime UAT;
- focused integration test;
- configuration/activation verification;
- security/authorization verification;
- migration/operational rehearsal;
- performance/concurrency test;
- external/Human evidence;
- no additional execution because current evidence is sufficient.

## CEP-069..078 boundary

Do **not** execute or remediate CEP-069..078 in this assessment.

Mark `post_cep069_078_recheck = YES` only where those CEPs or their likely production-readiness changes could materially change the Journey evidence/status.

A later delta assessment should revisit only those marked rows plus Journeys directly changed by subsequent commits.

## Boundaries

Do NOT:

- rediscover the Journey inventory;
- add/delete/renumber canonical Journey rows;
- execute UAT or browser workflows;
- create test data;
- mutate Development or Production data;
- modify application code;
- create migrations;
- rerun audits;
- change CEP/Gate states;
- perform Production actions;
- perform Git add/commit/push/reset/stash/clean;
- create duplicate evidence packs.

## Required output artifacts

Update only a copy of the prepared workbook, e.g.:

`docs/governance/journeys/BONIRA_JOURNEY_RISK_COVERAGE_ASSESSMENT_RESULT.xlsx`

Also produce one compact machine-readable CSV containing **only Critical/High gaps**:

`docs/governance/journeys/BONIRA_CRITICAL_HIGH_COVERAGE_GAPS.csv`

Do not create other reports unless required to explain an actual blocker.

## Final response

Return only:

1. current HEAD assessed;
2. Journeys assessed: `<n>/608`;
3. risk distribution: Critical / High / Medium / Low;
4. coverage distribution by status;
5. Critical total / sufficiently evidenced / gaps;
6. High total / sufficiently evidenced / gaps;
7. number requiring post-CEP-069..078 recheck;
8. `Candidate Missing Journey` count;
9. output workbook path;
10. Critical/High gap CSV path;
11. exact assessment blocker, if any.

Then STOP. Do not execute remediation or additional journeys.
